Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Berberine for acute gastrointestinal injury in septic shock
ChiCTR2000034974Phase 4Recruiting
- Sponsor
- Shenzhen Second People's Hospital
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of berberine in sepsis and Gastrointestinal injury (2 arms), sponsored by Shenzhen Second People's Hospital. Primary endpoint: AGI graded mitigation. Started Jul 2020; status: recruiting.
02
Drugs
berberine
03
Conditions
sepsisGastrointestinal injury
Beyond the preview
Go deeper on ChiCTR2000034974.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000034974.